Insulinpumpe ved behandling av diabetes hos barn og unge

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 11, 2009, Pages 1094-1097

  Frøisland, Dag Helge ^a   Solevåg, Anne Lee ^a   Markestad, Trond ^b  

^a Sykehuset Innlandet   (Norway)

^b Sykehuset Innlandet   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADOLESCENT; ARTICLE; BLOOD; CHILD; COMPARATIVE STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INTRADERMAL DRUG ADMINISTRATION; MALE; RETROSPECTIVE STUDY;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; RETROSPECTIVE STUDIES;

EID: 66549090653     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.32036     Document Type: Article

References (22)

1. Graue M, Wentzel-Larsen T, Hanestad BR et al. Measuring self-reported, health-related, quality of life in adolescents with type 1 diabetes using both generic and disease-specific instruments. Acta Paediatr 2003; 92: 1190-6.
2. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ 2004; 328: 750-4.
3. Strøm H, Engeland A, Eriksen E et al. Hvor mange og hvem behandles medikamentelt for diabetes mellitus? Tidsskr Nor Lægeforen 2006; 126: 768-70.
4. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of longterm complications in adolescents with insulindependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-88.
5. Alemzadeh R, Palma-Sisto P, Parton EA et al. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes. Diabetes Technol Ther 2005; 7: 587-96.
6. Graue M, Wentzel-Larsen T, Hanestad BR et al. Health-related quality of life and metabolic control in adolescents with diabetes: the role of parental care, control, and involvement. J Pediatr Nurs 2005; 20: 373-82.
7. Tamborlane WV. Fulfilling the promise of insulin pump therapy in childhood diabetes. Pediatr Diabetes 2006; 7 (suppl 4): 4-10.
8. Skrivarhaug T, Bangstad HJ, Stene LC et al. Longterm mortality in a nationwide cohort of childhoodonset type 1 diabetic patients in Norway. Diabetologia 2006; 49: 298-305.
9. Nahata L. Insulin therapy in pediatric patients with type I diabetes: continuous subcutaneous insulin infusion versus multiple daily injections. Clin Pediatr (Phila) 2006; 45: 503-8.
10. Maniatis AK, Klingensmith GJ, Slover RH et al. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001; 107: 351-6.
11. Plotnick LP, Clark LM, Brancati FL et al. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26: 1142-6.
12. Torrance T, Franklin V, Greene S. Insulin pumps. Arch Dis Child 2003; 88: 949-53.
13. Steindel BS, Roe TR, Costin G et al. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 1995; 27: 199-204.
14. Tubiana-Rufi N, Coutant R, Bloch J et al. Special management of insulin lispro in continuous subcutaneous insulin infusion in young diabetic children: a randomized cross-over study. Horm Res 2004; 62: 265-71.
15. Weintrob N, Benzaquen H, Galatzer A et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003; 112: 559-64.
16. Hanås R, Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes 2006; 7: 25-31.
17. Jakisch BI, Wagner VM, Heidtmann B et al. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric type 1 diabetes: a multicentre matchedpair cohort analysis over 3 years. Diabet Med 2008; 25: 80-5.
18. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 2563-9.
19. Barnard KD, Lloyd CE, Skinner TC. Systematic literature review: quality of life associated with insulin pump use in type 1 diabetes. Diabet Med 2007; 24: 607-17.
20. Cogen FR, Henderson C, Hansen JA et al. Pediatric quality of life in transitioning to the insulin pump: does prior regimen make a difference? Clin Pediatr (Phila) 2007; 46: 777-9.
21. Juliusson PB, Graue M, Wentzel-Larsen T et al. The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes. Acta Paediatr 2006; 95: 1481-7.
22. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes 2006; 7 (suppl 4): 32-8.